
Human Methyltransferase-like 26 21-29, YLDPAQRGV
Description
About Human Methyltransferase-like 26 21-29, YLDPAQRGV
The Human Methyltransferase-like 26 Peptide (IEDB: 194576) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Methyltransferase-like 26 Peptide, H-YLDPAQRGV-OH (Uniprot: Q96S19 aa: 21-29) from JPT is produced under strict quality control and quality management.
Human Methyltransferase-like 26 21-29, YLDPAQRGV - Specifications
- Peptide sequence: H-YLDPAQRGV-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Leukemia, Leukemia
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Methyltransferase-like 26 21-29, YLDPAQRGV
References:
Read References with JPT’s Antigen Peptides
Human Methyltransferase-like 26 21-29, YLDPAQRGV has been described in:
Two preferentially expressed proteins protect vascular endothelial cells from an attack by peptide-specific CTL., J Immunol, 2012 (PMID: 22544926)
An open-source computational and data resource to analyze digital maps of immunopeptidomes., Elife, 2015 (PMID: 26154972)
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans., Nature, 2021 (PMID: 34044428)
Documentation
Documentation for Human Methyltransferase-like 26 21-29, YLDPAQRGV
Properties
Properties of Human Methyltransferase-like 26 21-29, YLDPAQRGV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Leukemia |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Methyltransferase-like 26 21-29, YLDPAQRGV
Information | Values |
---|---|
Sequence: | H-YLDPAQRGV-OH |
Specifications: | 9mer peptide as TFA salt |